JP2017520763A5 - - Google Patents

Download PDF

Info

Publication number
JP2017520763A5
JP2017520763A5 JP2016571689A JP2016571689A JP2017520763A5 JP 2017520763 A5 JP2017520763 A5 JP 2017520763A5 JP 2016571689 A JP2016571689 A JP 2016571689A JP 2016571689 A JP2016571689 A JP 2016571689A JP 2017520763 A5 JP2017520763 A5 JP 2017520763A5
Authority
JP
Japan
Prior art keywords
protein
tumor
autoantibodies
bead
patient
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Pending
Application number
JP2016571689A
Other languages
English (en)
Japanese (ja)
Other versions
JP2017520763A (ja
Filing date
Publication date
Priority claimed from US14/321,867 external-priority patent/US9506925B2/en
Priority claimed from US14/321,870 external-priority patent/US9885718B2/en
Application filed filed Critical
Priority claimed from PCT/US2014/049038 external-priority patent/WO2016003479A1/en
Publication of JP2017520763A publication Critical patent/JP2017520763A/ja
Publication of JP2017520763A5 publication Critical patent/JP2017520763A5/ja
Pending legal-status Critical Current

Links

JP2016571689A 2014-07-02 2014-07-31 肝臓癌の非侵襲性診断のための特異的バイオマーカーセット Pending JP2017520763A (ja)

Applications Claiming Priority (5)

Application Number Priority Date Filing Date Title
US14/321,870 2014-07-02
US14/321,867 US9506925B2 (en) 2014-07-02 2014-07-02 Specific biomarker set for non-invasive diagnosis of liver cancer
US14/321,870 US9885718B2 (en) 2014-07-02 2014-07-02 Specific biomarker set for non-invasive diagnosis of liver cancer
US14/321,867 2014-07-02
PCT/US2014/049038 WO2016003479A1 (en) 2014-07-02 2014-07-31 Specific biomarker set for non-invasive diagnosis of liver cancer

Related Child Applications (1)

Application Number Title Priority Date Filing Date
JP2020106731A Division JP2020160082A (ja) 2014-07-02 2020-06-22 肝臓癌の非侵襲性診断のための特異的バイオマーカーセット

Publications (2)

Publication Number Publication Date
JP2017520763A JP2017520763A (ja) 2017-07-27
JP2017520763A5 true JP2017520763A5 (enExample) 2017-09-21

Family

ID=55019816

Family Applications (2)

Application Number Title Priority Date Filing Date
JP2016571689A Pending JP2017520763A (ja) 2014-07-02 2014-07-31 肝臓癌の非侵襲性診断のための特異的バイオマーカーセット
JP2020106731A Withdrawn JP2020160082A (ja) 2014-07-02 2020-06-22 肝臓癌の非侵襲性診断のための特異的バイオマーカーセット

Family Applications After (1)

Application Number Title Priority Date Filing Date
JP2020106731A Withdrawn JP2020160082A (ja) 2014-07-02 2020-06-22 肝臓癌の非侵襲性診断のための特異的バイオマーカーセット

Country Status (12)

Country Link
EP (1) EP3164711A4 (enExample)
JP (2) JP2017520763A (enExample)
KR (1) KR102086788B1 (enExample)
CN (2) CN105319362B (enExample)
AU (2) AU2014399919B2 (enExample)
CA (1) CA2939912C (enExample)
MY (2) MY195045A (enExample)
NZ (1) NZ722492A (enExample)
SG (1) SG11201606106SA (enExample)
TW (1) TWI700493B (enExample)
UY (1) UY36200A (enExample)
WO (1) WO2016003479A1 (enExample)

Families Citing this family (10)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN106383231B (zh) * 2016-09-02 2020-03-17 四川大学 一种诊断肝癌的标记物组合及其应用
GB201619954D0 (en) * 2016-11-25 2017-01-11 Oncimmune Ltd Antibody assay
KR102175265B1 (ko) 2019-03-13 2020-11-06 충남대학교산학협력단 Txndc7을 포함하는 간세포암종 진단 또는 예후 예측용 바이오마커 조성물
CN110646615B (zh) * 2019-08-27 2021-07-13 南方医科大学 肝纤维化的生物学标志物、治疗靶点及其用途
WO2023282916A1 (en) 2021-07-09 2023-01-12 Guardant Health, Inc. Methods of detecting genomic rearrangements using cell free nucleic acids
ES2987661T3 (es) 2020-07-10 2024-11-15 Guardant Health Inc Métodos de detección de reordenamientos genómicos utilizando ácidos nucleicos libres de células
CN113502328A (zh) * 2021-05-27 2021-10-15 深圳市人民医院 检测样本中标志物表达水平的试剂在制备用于检测或诊断乳腺癌的试剂盒中的应用
CN113777295B (zh) * 2021-09-15 2024-03-19 江南大学 用于检测肿瘤标志物pd-l1的高灵敏度量子点探针、制备方法及应用
CN113956344A (zh) * 2021-10-14 2022-01-21 江南大学 一种新型治疗肝癌的fgf类似物及其应用
CN114113611B (zh) * 2021-12-13 2023-07-14 郑州大学 一种用于肝癌诊断的生物标志物及检测试剂盒

Family Cites Families (15)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6449562B1 (en) * 1996-10-10 2002-09-10 Luminex Corporation Multiplexed analysis of clinical specimens apparatus and method
US6893844B1 (en) * 1998-09-22 2005-05-17 Long Yu DNA encoding a new human hepatoma derived growth factor and producing method thereof
US7387881B2 (en) * 2001-09-19 2008-06-17 The Regents Of The University Of Michigan Detection and treatment of cancers of the liver
AU2002361908A1 (en) * 2001-12-31 2003-07-24 Quark Biotech, Inc. Methods for identifying marker genes for cancer
GB0228900D0 (en) * 2002-12-11 2003-01-15 Ml Lab Plc Cancer Immunotherapy
JP3960614B2 (ja) * 2003-08-31 2007-08-15 株式会社イムノディア 抗ペプチド抗体測定法とペプチドワクチンのワクチン候補選択方法
GB0406215D0 (en) * 2004-03-19 2004-04-21 Procure Therapeutics Ltd Prostate stem cell
WO2005123944A1 (en) * 2004-06-18 2005-12-29 Roche Diagnostics Gmbh Use of protein pdx1 as a marker for breast cancer
JP5211315B2 (ja) 2006-07-25 2013-06-12 国立大学法人愛媛大学 腫瘍マーカ、腫瘍診断キットおよび腫瘍マーカの測定方法
KR20100040964A (ko) * 2007-08-10 2010-04-21 가꼬우호우징 효고 이카다이가쿠 신규 간암 마커
US8512963B2 (en) * 2009-11-25 2013-08-20 The Johns Hopkins University Detection and quantitation of full-length thioredoxin (TRX) and truncated thioredoxin (TRX 80) in complex samples
US9523680B2 (en) * 2010-06-30 2016-12-20 Ambergen, Inc. Global Proteomic screening of random bead arrays using mass spectrometry imaging
JP5493130B2 (ja) 2010-08-25 2014-05-14 国立大学法人山口大学 自己抗体の検出方法
EP2678448A4 (en) * 2011-02-22 2014-10-01 Caris Life Sciences Luxembourg Holdings S A R L CIRCULATING BIOMARKERS
US20130130355A1 (en) * 2011-09-28 2013-05-23 Armune Biosciences, Inc. Method and system of particle-phage epitope complex

Similar Documents

Publication Publication Date Title
JP2017520763A5 (enExample)
JP6672411B2 (ja) 癌療法を示すためのsrmアッセイ
ES2641294T3 (es) Nuevo anticuerpo para el diagnóstico y/o el pronóstico del cáncer
JP2012019790A5 (enExample)
Jeong et al. Plasmon‐enhanced single extracellular vesicle analysis for cholangiocarcinoma diagnosis
JP2015533788A5 (enExample)
US20170176423A1 (en) Magnetic programmable bead enzyme-linked immunosorbent assay
JP2016507723A5 (enExample)
RU2016116773A (ru) Способ выявления опухоли поджелудочной железы, антитела и набор для выявления опухоли поджелудочной железы
JP2009539082A5 (enExample)
WO2006110589A3 (en) Gammaretrovirus associated with cancer
WO2014167969A1 (ja) 大腸がんの検出方法
He et al. Analytical platform evaluation for quantification of ERG in prostate cancer using protein and mRNA detection methods
JP2019058171A (ja) Pd−l1に対するsrmアッセイ
WO2015182580A1 (ja) 大腸がんの転移検出方法
JP6441215B2 (ja) 肺組織像を細分類するためのsrm/mrm分析
JP2018515071A5 (enExample)
JP2012531612A5 (enExample)
Song et al. The value of circulating CYFRA21-1 expression in patients with nasopharyngeal carcinoma: a study of 529 subjects
Xu et al. Rta-IgG as a biomarker for diagnosis and post treatment prognostic of nasopharyngeal carcinoma
JP2018520366A5 (enExample)
CN108738347B (zh) 辅助肝细胞癌患者的再发风险预测的方法、装置、计算机程序制品及试剂盒
CN106383231B (zh) 一种诊断肝癌的标记物组合及其应用
RU2745060C2 (ru) Биомаркеры для комбинированной терапии, включающей ленватиниб и эверолимус
Wang et al. Distinguishing of tumor cell-targeting peptide ligands through a color-encoding microarray